168 related articles for article (PubMed ID: 20839585)
1. Two-year treatment outcomes of patients enrolled in India's national first-line antiretroviral therapy programme.
Bachani D; Garg R; Rewari BB; Hegg L; Rajasekaran S; Deshpande A; Emmanuel KV; Chan P; Rao KS
Natl Med J India; 2010; 23(1):7-12. PubMed ID: 20839585
[TBL] [Abstract][Full Text] [Related]
2. Preliminary outcomes of a paediatric highly active antiretroviral therapy cohort from KwaZulu-Natal, South Africa.
Reddi A; Leeper SC; Grobler AC; Geddes R; France KH; Dorse GL; Vlok WJ; Mntambo M; Thomas M; Nixon K; Holst HL; Karim QA; Rollins NC; Coovadia HM; Giddy J
BMC Pediatr; 2007 Mar; 7():13. PubMed ID: 17367540
[TBL] [Abstract][Full Text] [Related]
3. Earlier initiation of antiretroviral therapy, increased tuberculosis case finding and reduced mortality in a setting of improved HIV care: a retrospective cohort study.
Hermans SM; van Leth F; Manabe YC; Hoepelman AI; Lange JM; Kambugu A
HIV Med; 2012 Jul; 13(6):337-44. PubMed ID: 22296211
[TBL] [Abstract][Full Text] [Related]
4. Immunologic response to antiretroviral therapy in hepatitis C virus-coinfected adults in a population-based HIV/AIDS treatment program.
Braitstein P; Zala C; Yip B; Brinkhof MW; Moore D; Hogg RS; Montaner JS
J Infect Dis; 2006 Jan; 193(2):259-68. PubMed ID: 16362890
[TBL] [Abstract][Full Text] [Related]
5. [Survival and immune response of rural HIV/AIDS patients after free antiretroviral therapy].
Ding YY; Jia WQ; Wang JS; Dong SL; Yang QH; Zhou RY; Qu SX; Lu LX; Wei J; Qiao XC; Gao MY; Guo XL; Zhang TJ; Wu ZY; He N
Zhonghua Liu Xing Bing Xue Za Zhi; 2008 Dec; 29(12):1176-80. PubMed ID: 19173958
[TBL] [Abstract][Full Text] [Related]
6. Predictors of failure of first-line antiretroviral therapy in HIV-infected adults: Indian experience.
Rajasekaran S; Jeyaseelan L; Vijila S; Gomathi C; Raja K
AIDS; 2007 Jul; 21 Suppl 4():S47-53. PubMed ID: 17620752
[TBL] [Abstract][Full Text] [Related]
7. Interruption of antiretroviral treatment in HIV-infected patients with preserved immune function is associated with a low rate of clinical progression: a prospective study by AIDS Clinical Trials Group 5170.
Skiest DJ; Su Z; Havlir DV; Robertson KR; Coombs RW; Cain P; Peterson T; Krambrink A; Jahed N; McMahon D; Margolis DM;
J Infect Dis; 2007 May; 195(10):1426-36. PubMed ID: 17436222
[TBL] [Abstract][Full Text] [Related]
8. Determinants of survival in AIDS patients on antiretroviral therapy in a rural centre in the Far-North Province, Cameroon.
Sieleunou I; Souleymanou M; Schönenberger AM; Menten J; Boelaert M
Trop Med Int Health; 2009 Jan; 14(1):36-43. PubMed ID: 19017309
[TBL] [Abstract][Full Text] [Related]
9. The prognostic value of baseline CD4(+) cell count beyond 6 months of antiretroviral therapy in HIV-positive patients in a resource-limited setting.
Mills EJ; Bakanda C; Birungi J; Yaya S; Ford N;
AIDS; 2012 Jul; 26(11):1425-9. PubMed ID: 22526520
[TBL] [Abstract][Full Text] [Related]
10. Characteristics, determinants, and clinical relevance of CD4 T cell recovery to <500 cells/microL in HIV type 1-infected individuals receiving potent antiretroviral therapy.
Kaufmann GR; Furrer H; Ledergerber B; Perrin L; Opravil M; Vernazza P; Cavassini M; Bernasconi E; Rickenbach M; Hirschel B; Battegay M;
Clin Infect Dis; 2005 Aug; 41(3):361-72. PubMed ID: 16007534
[TBL] [Abstract][Full Text] [Related]
11. Initiation of antiretroviral therapy in advanced AIDS with active tuberculosis: clinical experiences from Thailand.
Sungkanuparph S; Manosuthi W; Kiertiburanakul S; Vibhagool A
J Infect; 2006 Mar; 52(3):188-94. PubMed ID: 15992932
[TBL] [Abstract][Full Text] [Related]
12. Antiretroviral therapy in AIDS patients with CMV disease: impact on the survival and long-term treatment outcome.
Sungkanuparph S; Chakriyanuyok T; Butthum B
J Infect; 2008 Jan; 56(1):40-3. PubMed ID: 18037166
[TBL] [Abstract][Full Text] [Related]
13. Long-term prognosis of HIV-infected patients with Kaposi sarcoma treated with pegylated liposomal doxorubicin.
Martín-Carbonero L; Palacios R; Valencia E; Saballs P; Sirera G; Santos I; Baldobí F; Alegre M; Goyenechea A; Pedreira J; González del Castillo J; Martínez-Lacasa J; Ocampo A; Alsina M; Santos J; Podzamczer D; González-Lahoz J;
Clin Infect Dis; 2008 Aug; 47(3):410-7. PubMed ID: 18582203
[TBL] [Abstract][Full Text] [Related]
14. Association between older age and adverse outcomes on antiretroviral therapy: a cohort analysis of programme data from nine countries.
Greig J; Casas EC; O'Brien DP; Mills EJ; Ford N
AIDS; 2012 Jul; 26 Suppl 1():S31-7. PubMed ID: 22781173
[TBL] [Abstract][Full Text] [Related]
15. Antiretroviral therapy in a thousand patients with AIDS in Haiti.
Severe P; Leger P; Charles M; Noel F; Bonhomme G; Bois G; George E; Kenel-Pierre S; Wright PF; Gulick R; Johnson WD; Pape JW; Fitzgerald DW
N Engl J Med; 2005 Dec; 353(22):2325-34. PubMed ID: 16319381
[TBL] [Abstract][Full Text] [Related]
16. Long-term effectiveness of highly active antiretroviral therapy on the survival of children and adolescents with HIV infection: a 10-year follow-up study.
Patel K; Hernán MA; Williams PL; Seeger JD; McIntosh K; Van Dyke RB; Seage GR;
Clin Infect Dis; 2008 Feb; 46(4):507-15. PubMed ID: 18199042
[TBL] [Abstract][Full Text] [Related]
17. Generic fixed-dose combination antiretroviral treatment in resource-poor settings: multicentric observational cohort.
Calmy A; Pinoges L; Szumilin E; Zachariah R; Ford N; Ferradini L;
AIDS; 2006 May; 20(8):1163-9. PubMed ID: 16691068
[TBL] [Abstract][Full Text] [Related]
18. Total lymphocyte count as a possible surrogate of CD4 cell count to prioritize eligibility for antiretroviral therapy among HIV-infected individuals in resource-limited settings.
Bedell R; Heath KV; Hogg RS; Wood E; Press N; Yip B; O'Shaughnessy MV; Montaner JS
Antivir Ther; 2003 Oct; 8(5):379-84. PubMed ID: 14640384
[TBL] [Abstract][Full Text] [Related]
19. In resource-limited settings good early outcomes can be achieved in children using adult fixed-dose combination antiretroviral therapy.
O'Brien DP; Sauvageot D; Zachariah R; Humblet P;
AIDS; 2006 Oct; 20(15):1955-60. PubMed ID: 16988517
[TBL] [Abstract][Full Text] [Related]
20. Effect of highly active antiretroviral therapy on CD4 count and weight in AIDS patients seen at the UITH, Ilorin.
Olawumi HO; Olatunji PO; Salami AK; Odeigah L; Iseniyi JO
Niger J Clin Pract; 2008 Dec; 11(4):312-5. PubMed ID: 19320401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
